SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the main focus, with management saying the application is in final review and reaffirming confidence in the therapy. Traders are reading comments about possible labeling as encouraging, fueling bullish positioning and short-squeeze speculation, while others stress that approval remains uncertain and the decision is a binary risk.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras positive Phase 2 results for ABCL635, its investigational treatment for menopausal hot flashes, alongside upbeat management comments, analyst target increases and new pipeline programs, are driving attention. Many traders see substantial potential, while others are frustrated by the stocks weak reaction and emphasize that durability data and progress toward Phase 3 remain key tests.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes sonelokimab BLA for hidradenitis suppurativa and the pending FDA filing-acceptance decision are driving attention, with traders also weighing whether the agency will grant priority review. Sentiment is split between optimism about the drugs clinical data and commercial potential, and concerns about regulatory risk, managements plan to launch independently, and possible future dilution.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention after reporting record quarterly revenue and its first positive adjusted EBITDA, with traders focused on Quake AIs contribution and the companys shift toward AI infrastructure. Many are bullish and anticipating a short squeeze, while others question cash needs, financing and data-center expansion timelines.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A broad semiconductor rebound tied to CoreWeaves strong results and renewed confidence in AI-infrastructure demand has lifted AMD. Traders are cheering AMDs strength and some see money rotating from Nvidia, while others warn the rapid rally may be overextended and expect profit-taking.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Repeated extensions in Aurinias generic-drug patent litigation are keeping attention on the timing and outcome of the cases, with traders frustrated by the delays and the companys limited communication. Some speculate that the cases could settle or lead to a buyout, but neither outcome is confirmed; others point to the recent revenue-guidance increase as a positive counterweight.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

Cardinals steep selloff has centered on concerns that the Hughes Brothers acquisition is overpriced and could burden shareholders through dilution and financing, compounded by worries about squeezed margins and managements credibility. Some traders see the shares as oversold and undervalued, while others remain concerned about the deal and further declines; posts also mention securities-law investigations, but those claims are not established here.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUEs strong initial commercial launch and better-than-expected product revenue are driving attention, but RVMD shares have sold off sharply despite the upbeat results. Traders are debating whether the decline reflects profit-taking and concerns about launch durability and rising expenses or an overreaction to the companys early commercial momentum.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is drawing attention ahead of its upcoming earnings report, with traders focused on whether AI-driven chipmaking investment and equipment orders support the outlook. The recent rally and call-heavy options activity have encouraged bullish positioning, while others warn that fab spending could weaken and make the shares vulnerable to a pullback.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos earnings and AI-networking demand are driving attention, with traders reacting to strong reported results and renewed optimism about its role in data-center infrastructure. Others question whether hyperscaler orders will prove durable and offset margin concerns, keeping the debate focused on the sustainability of the AI-driven growth story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on December 1, 2026 to shareholders of record at the close of business on November 18, 2026. The ex-dividend date is November 18, 2026. The previous...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on November 2, 2026 to shareholders of record at the close of business on October 19, 2026. The ex-dividend date is October 19, 2026. The previous...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on October 1, 2026 to shareholders of record at the close of business on September 17, 2026. The ex-dividend date is September 17, 2026. The previous...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on September 1, 2026 to shareholders of record at the close of business on August 18, 2026. The ex-dividend date is August 18, 2026. The previous distribution...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on August 3, 2026 to shareholders of record at the close of business on July 17, 2026. The ex-dividend date is July 17, 2026. The previous distribution...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on July 1, 2026 to shareholders of record at the close of business on June 16, 2026. The ex-dividend date is June 16, 2026. The previous distribution...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0500 per share of common stock, payable on June 1, 2026 to shareholders of record at the close of...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0420 per share of common stock, payable on May 1, 2026 to shareholders of record at the close of...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0420 per share of common stock, payable on April 1, 2026 to shareholders of record at the close of...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0420 per share of common stock, payable on March 2, 2026 to shareholders of record at the close of...

BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a non-diversified closed-end management investment company. Its investment objective is to seek to provide as high a level of current income exempt from regular federal income tax as is consistent with the preservation of capital. The company was founded on April 26, 2013 and is headquartered in New York, NY.

BNY Mellon Municipal Bond Infrastructure Fund Inc

Neutral Sentiment

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Current Price	$10.31
Prev Close	$10.27
Open	$10.27
Dividend Yield	4.10%
50-Day Moving Average	$9.90
Beta	0.18
Avg. Volume	116,494.39
PE Ratio	12.32

52-Week High	$11.28
52-Week Low	$9.19
Market Capitalization	$189.03M
EPS (Annual)	$0.3011
Price to Book	0.91
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

DMB Fundamentals